Resumo

DIAZ-LLOPIS, M. et al. Intravitreal injection of bevacizumab for pseudophakic cystoid macular edema resistant to steroids. Arch Soc Esp Oftalmol [online]. 2007, vol.82, n.7, pp.447-450. ISSN 0365-6691.

Clinical case: A 71-year-old man presented with pseudophakic cystoid macular edema (PCME) and a visual acuity (VA) of 0.1. He had been treated with 2 intra-vitreal injections of triamcinolone acetonide (4 mg) 16 months previously. One week after the intra-vitreal injection of bevacizumab (1.25 mg), VA improved to 0.33, and the OCT demonstrated decreased macular thickness. Two months after the injection, no ocular complications were observed, VA was 0.5 and the OCT showed a significant reduction in the retinal thickness. Conclusion: Intra-vitreal injection of bevacizumab may be an additional tool for the treatment of therapy-resistant PCME.

Palavras-chave : Bevacizumab; intra-vitreal injection; pseudophakic cystoid macular edema; cataract surgery; corticoid resistant.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )